Cadila Pharmaceuticals Ltd, Dr. Rajiv Modi, has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
IRMENERGY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IRM Energy's promoters – Dr. Rajiv Modi, IRM Trust, and Cadila Pharmaceuticals Limited – have submitted annual disclosures under SEBI's Regulation 31(4) to the stock exchanges and the audit committee. All three entities declared that neither they nor any person acting in concert (PAC) has encumbered (pledged or otherwise locked) any shares of IRM Energy Limited, directly or indirectly, during financial year 2024-25. The declaration is a routine annual compliance requirement for promoters confirming no share encumbrance activity for the year.
This is a neutral-to-mildly positive compliance filing for shareholders. It confirms that no promoter shares were pledged or otherwise encumbered during the year, indicating no hidden leverage or collateral risk on the promoter stake. No immediate effect on stock price is expected as this is a standard annual disclosure.